Among the three, only [18F]RO‐948 was recommended for further investigation as minimal binding was found in controls and patients with AD had region‐specific patterns of tracer uptake consistent with pathohistological data for the spread of tau pathology (Wong et al., 2018). The gene discussed is MAPT; the disease is Alzheimer disease.